THE EFFECTIVENESS OF ULINASTATIN IN PATIENTS WITH CHRONIC PANCREATITIS

dc.contributor.author	Karimov M., Sobirova G.,Ismailova J.
dc.date.accessioned	2022-12-13T10:51:01Z
dc.date.available	2022-12-13T10:51:01Z
dc.date.issued	2022-12
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/5012
dc.description.abstract	The article presents the results of the anti-inflammatory efficacy of the new generation protease inhibitor ulinastatin in the treatment of exacerbation of chronic pancreatitis of moderate severity. It is shown that exacerbation of chronic pancreatitis of alimentary, alcoholic and biliary etiology was expressed by abdominal pain and dyspeptic symptoms. An increase in the level of serum aminotransferases, bilirubin and alpha amylase was noted, which was accompanied by a significant increase in the activity of pro-inflammatory cytokines. The use of ulinastatin in the complex of pharmacotherapy of chronic pancreatitis contributed to the effective relief of exacerbation of pancreatitis, which was due to the anticytokine effect of the drug.	en_US
dc.language.iso	en	en_US
dc.publisher	Norwegian Journal of development of the International Science No 95/2022	en_US
dc.relation.ispartofseries	УДК: 616.37-002.2(075.8);
dc.subject	chronic pancreatitis, ULINASTATIN, abdominal pain, dyspeptic symptoms	en_US
dc.title	THE EFFECTIVENESS OF ULINASTATIN IN PATIENTS WITH CHRONIC PANCREATITIS	en_US
dc.title.alternative	Norwegian Journal of development of the International Science No 95/2022	en_US
dc.type	Article	en_US